Neuromodulation Devices Market Report 2024-2034

Neuromodulation Devices Market Report 2024-2034



The Neuromodulation devices market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation

The demand for deep brain stimulation (DBS) in neuromodulation has experienced a notable surge, driven by factors such as expanded applications, technological advancements, positive clinical outcomes, progress in neurological research, and increased awareness among patients and healthcare providers. This surge reflects the growing acceptance of DBS as an effective therapeutic intervention for various neurological disorders. Ongoing developments in the field of neuromodulation continue to contribute to the increased demand for DBS, showcasing its potential to address diverse medical conditions and improve patient outcomes.

Complications Associated with Usage of Neuromodulation Devices

The use of neuromodulation devices, while offering therapeutic benefits, is not without potential complications. Complications associated with these devices can include infection at the implantation site, hardware malfunctions, lead migration or breakage, and adverse reactions to electrical stimulation. Additionally, patients may experience side effects such as tingling, pain, or muscle contractions. Proper patient selection, precise surgical placement, and ongoing monitoring are crucial to minimizing risks. Despite the efficacy of neuromodulation, the potential for complications underscores the importance of careful patient evaluation, thorough preoperative planning, and vigilant postoperative management to ensure the safe and effective use of these devices in managing various neurological conditions.

What Questions Should You Ask before Buying a Market Research Report?
  • How is the Neuromodulation devices market evolving?
  • What is driving and restraining the neuromodulation devices market?
  • How will each neuromodulation devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each Neuromodulation devices submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading neuromodulation devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the neuromodulation devices projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of neuromodulation devices projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the neuromodulation devices market?
  • Where is the neuromodulation devices market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Neuromodulation devices market today, and over the next 10 years:
  • Our 251-page report provides 96 tables and 133 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Neuromodulation devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Neuromodulation devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Product
  • Deep Brain Stimulator
  • Gastric Electric Stimulator
  • Spinal Cord Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Transcutaneous Electrical Nerve Stimulator
  • Others
By Application
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets

North America
  • U.S.
  • Canada
Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
MEA
  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Neuromodulation devices market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report
  • Abbott
  • Boston Scientific Corporation
  • electroCore, Inc.
  • Helbling Holding AG
  • Innovative Health Solutions
  • LivaNova PLC
  • Medtronic
  • MicroTransponder Inc.
  • Neuronetics Inc.
  • Parasym
  • Synapse Biomedical Inc.
  • tVNS Technologies GmbH
Overall world revenue for Neuromodulation devices market, 2024 to 2034 in terms of value the market will surpass US$10.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Neuromodulation devices market, 2024 to 2034 report help you?

In summary, our 250+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Neuromodulation devices market, 2024 to 2034 Market, with forecasts for product, application and route of administration, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 21 key national markets – See forecasts for the Neuromodulation devices market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 12 of the major companies involved in the Neuromodulation devices market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Neuromodulation devices market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..

The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.


1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Neuromodulation Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Demand for Deep Brain Stimulator Neuromodulation Devices in Pharmaceutical and Biotechnology Industry
3.2.1.2 Rising Prevalence of Neurological Disorders and Nerve Injuries
3.2.1.3 Growing Preference Among Patients for Non-invasive Treatments
3.2.1.4 Expanded Therapeutic Applications of Neuromodulation Devices
3.2.1.5 Technological Advancements in Neuromodulation Devices
3.2.2 Market Restraining Factors
3.2.2.1 Complications Associated with Usage of Neuromodulation Devices
3.2.2.2 High Cost of Neuromodulation Devices
3.2.2.3 Stringent Regulatory Framework and a Thorough Approval Process
3.2.2.4 Preference for Drug Therapies over Neuromodulation Products
3.2.2.5 Product Recalls in the Neuromodulation Devices
3.2.2.6 Lack of Skilled Healthcare Practitioners
3.2.3 Market Opportunities
3.2.3.1 Rising Demand for Minimally Invasive Surgeries in Developed Countries
3.2.3.2 Increasing Number of Elderly Patients with Neurological Disorders
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Neuromodulation Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Neuromodulation Devices Market Size Estimation and Forecast by Product
4.4 Deep Brain Stimulator
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Gastric Electric Stimulator
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Spinal Cord Stimulator
4.6.1 Market Size by Region, 2024-2034 (US$ Million)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Sacral Nerve Stimulator
4.7.1 Market Size by Region, 2024-2034 (US$ Million)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Vagus Nerve Stimulator
4.8.1 Market Size by Region, 2024-2034 (US$ Million)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Transcutaneous Electrical Nerve Stimulator
4.9.1 Market Size by Region, 2024-2034 (US$ Million)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Others
4.10.1 Market Size by Region, 2024-2034 (US$ Million)
4.10.2 Market Share by Region, 2024 & 2034 (%)
5 Neuromodulation Devices Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Neuromodulation Devices Market Size Estimation and Forecast by Application
5.4 Pain Management
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Epilepsy
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Essential Tremor
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Urinary and Fecal Incontinence
5.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Depression
5.8.1 Market Size by Region, 2024-2034 (US$ Million)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Dystonia
5.9.1 Market Size by Region, 2024-2034 (US$ Million)
5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Gastroparesis
5.10.1 Market Size by Region, 2024-2034 (US$ Million)
5.10.2 Market Share by Region, 2024 & 2034 (%)
5.11 Parkinson’s Disease
5.11.1 Market Size by Region, 2024-2034 (US$ Million)
5.11.2 Market Share by Region, 2024 & 2034 (%)
5.12 Others
5.12.1 Market Size by Region, 2024-2034 (US$ Million)
5.12.2 Market Share by Region, 2024 & 2034 (%)
6 Neuromodulation Devices Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Neuromodulation Devices Market Analysis
7.1 Key Findings
7.2 North America Neuromodulation Devices Market Attractiveness Index
7.3 North America Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
7.4 North America Neuromodulation Devices Market Size Estimation and Forecast by Country
7.5 North America Neuromodulation Devices Market Size Estimation and Forecast by Product
7.6 North America Neuromodulation Devices Market Size Estimation and Forecast by Application
7.7 U.S. Neuromodulation Devices Market Analysis
7.8 Canada Neuromodulation Devices Market Analysis
8 Europe Neuromodulation Devices Market Analysis
8.1 Key Findings
8.2 Europe Neuromodulation Devices Market Attractiveness Index
8.3 Europe Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
8.4 Europe Neuromodulation Devices Market Size Estimation and Forecast by Country
8.5 Europe Neuromodulation Devices Market Size Estimation and Forecast by Product
8.6 Europe Neuromodulation Devices Market Size Estimation and Forecast by Application
8.7 Germany Neuromodulation Devices Market Analysis
8.8 France Neuromodulation Devices Market Analysis
8.9 UK Neuromodulation Devices Market Analysis
8.10 Italy Neuromodulation Devices Market Analysis
8.11 Spain Neuromodulation Devices Market Analysis
8.12 Russia Neuromodulation Devices Market Analysis
8.13 Rest of Europe Neuromodulation Devices Market Analysis
9 Asia Pacific Neuromodulation Devices Market Analysis
9.1 Key Findings
9.2 Asia Pacific Neuromodulation Devices Market Attractiveness Index
9.3 Asia Pacific Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
9.4 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Country
9.5 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Product
9.6 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Application
9.7 Japan Neuromodulation Devices Market Analysis
9.8 China Neuromodulation Devices Market Analysis
9.9 India Neuromodulation Devices Market Analysis
9.10 Australia Neuromodulation Devices Market Analysis
9.11 South Korea Neuromodulation Devices Market Analysis
9.12 Rest of Asia Pacific Neuromodulation Devices Market Analysis
10 Latin America Neuromodulation Devices Market Analysis
10.1 Key Findings
10.2 Latin America Neuromodulation Devices Market Attractiveness Index
10.3 Latin America Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
10.4 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Country
10.5 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Product
10.6 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Application
10.7 Brazil Neuromodulation Devices Market Analysis
10.8 Mexico Neuromodulation Devices Market Analysis
10.9 Rest of Latin America Neuromodulation Devices Market Analysis
11 MEA Neuromodulation Devices Market Analysis
11.1 Key Findings
11.2 MEA Neuromodulation Devices Market Attractiveness Index
11.3 MEA Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 MEA Neuromodulation Devices Market Size Estimation and Forecast by Country
11.5 MEA Neuromodulation Devices Market Size Estimation and Forecast by Product
11.6 MEA Neuromodulation Devices Market Size Estimation and Forecast by Application
11.7 GCC Neuromodulation Devices Market Analysis
11.8 South Africa Neuromodulation Devices Market Analysis
11.9 Rest of MEA Neuromodulation Devices Market Analysis
12 Company Profiles
12.1 Competitive Landscape, 2022
12.2 Strategic Outlook
12.3 Abbott
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2017-2022
12.3.3.2 R&D, 2017-2022
12.3.3.3 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Boston Scientific Corporation
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2022
12.4.3.2 R&D, 2017-2022
12.4.3.3 Regional Market Shares, 2022
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 electroCore, Inc.
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2017-2022
12.5.3.2 R&D, 2017-2022
12.5.3.3 Regional Market Shares, 2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 Helbling Holding AG
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2022
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 Innovative Health Solutions
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Product Benchmarking
12.8 LivaNova PLC
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2022
12.8.3.2 R&D, 2017-2022
12.8.3.3 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Medtronic
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2017-2022
12.9.3.2 R&D, 2017-2022
12.9.3.3 Regional Market Shares, 2022
12.9.4 Product Benchmarking
12.9.5 Strategic Outlook
12.10 MicroTransponder Inc.
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Product Benchmarking
12.10.4 Strategic Outlook
12.11 Neuronetics Inc.
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.3.3 Regional Market Shares, 2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Parasym
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Synapse Biomedical Inc
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
12.13.4 Strategic Outlook
12.14 tVNS Technologies GmbH
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.14.4 Strategic Outlook
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings